Author:
Cheung Michelle C.M.,Walker Alex J.,Hudson Benjamin E.,Verma Suman,McLauchlan John,Mutimer David J.,Brown Ashley,Gelson William T.H.,MacDonald Douglas C.,Agarwal Kosh,Foster Graham R.,Irving William L.
Reference15 articles.
1. Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease;Charlton;Gastroenterology,2015
2. Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis;Curry;N Engl J Med,2015
3. Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV infection and decompensated cirrhosis: interim analysis of a French multicentre compassionate use programme European association for the study of the liver;Leroy,2016
4. Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV infection in patients with decompensated cirrhosis: results of a European Multicentre Compassionate Use Programme. European Association for the Study of the Liver;Petersen,2016
5. Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution;Reig;J Hepatol,2016
Cited by
350 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献